Annual CFF
$18.41 M
-$5.58 M-23.24%
December 1, 2024
Summary
- As of February 26, 2025, KRBP annual cash flow from financing activities is $18.41 million, with the most recent change of -$5.58 million (-23.24%) on December 1, 2024.
- During the last 3 years, KRBP annual CFF has fallen by -$18.92 million (-50.68%).
- KRBP annual CFF is now -50.68% below its all-time high of $37.34 million, reached on December 31, 2021.
Performance
KRBP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.42 M
+$1.39 M+135.15%
December 1, 2024
Summary
- As of February 26, 2025, KRBP quarterly cash flow from financing activities is $2.42 million, with the most recent change of +$1.39 million (+135.15%) on December 1, 2024.
- Over the past year, KRBP quarterly CFF has stayed the same.
- KRBP quarterly CFF is now -93.48% below its all-time high of $37.03 million, reached on September 30, 2021.
Performance
KRBP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$18.41 M
-$1.93 M-9.47%
December 1, 2024
Summary
- As of February 26, 2025, KRBP TTM cash flow from financing activities is $18.41 million, with the most recent change of -$1.93 million (-9.47%) on December 1, 2024.
- Over the past year, KRBP TTM CFF has stayed the same.
- KRBP TTM CFF is now -62.86% below its all-time high of $49.58 million, reached on September 30, 2021.
Performance
KRBP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KRBP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.2% | 0.0% | 0.0% |
| 3 y3 years | -50.7% | -66.0% | +9.0% |
| 5 y5 years | +286.8% | -66.0% | +9.0% |
KRBP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.7% | +371.9% | -72.5% | +1513.9% | -50.7% | >+9999.0% |
| 5 y | 5-year | -50.7% | +371.9% | -93.5% | +1513.9% | -62.9% | >+9999.0% |
| alltime | all time | -50.7% | +1033.2% | -93.5% | +1513.9% | -62.9% | >+9999.0% |
Kiromic BioPharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.41 M(-23.2%) | $2.42 M(+135.2%) | $18.41 M(-9.5%) |
| Sep 2024 | - | $1.03 M(-88.3%) | $20.34 M(-22.7%) |
| Jun 2024 | - | $8.78 M(+41.8%) | $26.32 M(+6.8%) |
| Mar 2024 | - | $6.19 M(+42.6%) | $24.65 M(+2.7%) |
| Dec 2023 | $23.99 M(+514.7%) | $4.34 M(-38.0%) | $23.99 M(-0.1%) |
| Sep 2023 | - | $7.00 M(-1.5%) | $24.01 M(+42.1%) |
| Jun 2023 | - | $7.11 M(+28.4%) | $16.89 M(+75.8%) |
| Mar 2023 | - | $5.54 M(+27.1%) | $9.61 M(+146.2%) |
| Dec 2022 | $3.90 M(-89.5%) | $4.36 M(-3892.2%) | $3.90 M(>+9900.0%) |
| Sep 2022 | - | -$114.90 K(-32.7%) | $100.00(-100.0%) |
| Jun 2022 | - | -$170.80 K(+1.2%) | $37.14 M(-0.4%) |
| Mar 2022 | - | -$168.80 K(-137.1%) | $37.30 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $37.34 M(+136.2%) | $454.60 K(-98.8%) | $37.34 M(-24.7%) |
| Sep 2021 | - | $37.03 M(<-9900.0%) | $49.58 M(+295.4%) |
| Jun 2021 | - | -$10.80 K(-92.0%) | $12.54 M(-1.0%) |
| Mar 2021 | - | -$134.60 K(-101.1%) | $12.67 M(-19.8%) |
| Dec 2020 | $15.81 M(+232.0%) | $12.70 M(<-9900.0%) | $15.81 M(+161.6%) |
| Sep 2020 | - | -$10.00 K(-108.3%) | $6.04 M(-20.8%) |
| Jun 2020 | - | $120.50 K(-96.0%) | $7.63 M(+0.3%) |
| Mar 2020 | - | $3.00 M(+2.4%) | $7.61 M(+59.9%) |
| Dec 2019 | $4.76 M(+193.0%) | $2.93 M(+85.4%) | $4.76 M(+160.1%) |
| Sep 2019 | - | $1.58 M(+1480.9%) | $1.83 M(+632.4%) |
| Jun 2019 | - | $100.00 K(-33.3%) | $250.00 K(+66.7%) |
| Mar 2019 | - | $150.00 K | $150.00 K |
| Dec 2018 | $1.63 M | - | - |
FAQ
- What is Kiromic BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for Kiromic BioPharma?
- What is Kiromic BioPharma annual CFF year-on-year change?
- What is Kiromic BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly CFF year-on-year change?
- What is Kiromic BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kiromic BioPharma?
- What is Kiromic BioPharma TTM CFF year-on-year change?
What is Kiromic BioPharma annual cash flow from financing activities?
The current annual CFF of KRBP is $18.41 M
What is the all time high annual CFF for Kiromic BioPharma?
Kiromic BioPharma all-time high annual cash flow from financing activities is $37.34 M
What is Kiromic BioPharma annual CFF year-on-year change?
Over the past year, KRBP annual cash flow from financing activities has changed by -$5.58 M (-23.24%)
What is Kiromic BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of KRBP is $2.42 M
What is the all time high quarterly CFF for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly cash flow from financing activities is $37.03 M
What is Kiromic BioPharma quarterly CFF year-on-year change?
Over the past year, KRBP quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Kiromic BioPharma TTM cash flow from financing activities?
The current TTM CFF of KRBP is $18.41 M
What is the all time high TTM CFF for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM cash flow from financing activities is $49.58 M
What is Kiromic BioPharma TTM CFF year-on-year change?
Over the past year, KRBP TTM cash flow from financing activities has changed by $0.00 (0.00%)